As a Postdoctoral Fellow leading a research team at the Australian National University, I leverage innovations in RNA therapeutics to develop and commercialize cutting-edge treatments for sight-threatening retinal degenerations. My focus is on uniting key stakeholders—patients, researchers, and ophthalmic drug development companies—to accelerate the development of sight-saving therapies for those in need.companies to experidate the development of treatments for retinal degenerations and save… Show more As a Postdoctoral Fellow leading a research team at the Australian National University, I leverage innovations in RNA therapeutics to develop and commercialize cutting-edge treatments for sight-threatening retinal degenerations. My focus is on uniting key stakeholders—patients, researchers, and ophthalmic drug development companies—to accelerate the development of sight-saving therapies for those in need.companies to experidate the development of treatments for retinal degenerations and save sight for the patients that needed most. Show less

As CTO and co-founder of a startup developing a patented blood-derived therapeutic for age-related macular degeneration, I generated the IP for lead product manufacturing and oversee data analytics, CMC protocols, financial modeling, valuation, and market sizing.

As a Research Associate at a leading ophthalmology institute, my role involves providing expert consulting services in bioinformatics, data analytics, and statistical modelling. I support institute staff in retinal disease modelling, preclinical animal work, and the application of advanced analytical techniques to drive research on retinal diseases.